Back to Journals Journal of Hepatocellular Carcinoma Volume 12 Natural Bioactive Compounds Targeting the Wnt/-Catenin Pathway for the Treatment of Hepatocellular Carcinoma Authors Tian H, Wang P, Shao H Received 19 February 2025 Accepted for publication 11 July 2025 Published 23 July 2025 Volume 2025:12 Pages 16131622 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Ali Hosni Haoyu Tian, Peng Wang, Haibo Shao Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, Liaoning, Peoples Republic of China Correspondence: Haibo Shao, Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, Peoples Republic of China, Email [email protected] Abstract: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited treatment options and poor prognosis
Furthermore, the incidence of grade 3 or higher TRAEs was 25.6% among those who received dato-DXd vs 42.1% in patients who received paclitaxel in TROPION-Lung01
10.3389/fpubh.2017.00335 82 JiL.-L.ShengY.-C.ZhengZ.-Y.ShiL.WangZ.-T
Ultimately, mastering the skill to calculate AHK-Cu dosage is about more than just numbers
Depending on when I'm training that day, I'll either shower or not shower
O., Podgaec, S., Dias Jr, J
